A Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Study to Demonstrate Efficacy and Safety of DFL24498 Eye Drop Solution in Adult Participants with Atopic Keratoconjunctivitis (AKC) - ICY-AKC-301
Latest Information Update: 01 Dec 2025
At a glance
- Drugs Isocyclosporin-A-Dompe-Farmaceutici (Primary)
- Indications Allergic conjunctivitis
- Focus Therapeutic Use
- Sponsors Dompe Farmaceutici
Most Recent Events
- 01 Dec 2025 New trial record